Cochlear and vestibular ion transport
耳蜗和前庭离子传输
基本信息
- 批准号:7252556
- 负责人:
- 金额:$ 36.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAdrenal Cortex HormonesAdrenergic AgentsAdrenergic beta-AgonistsAnionsAreaAwardBathingBicarbonatesBindingCalciumCarrier ProteinsCationsCell LineCellsClinicalCochleaCochlear ductCommunitiesComplement component C1sConditionCyclic AMPCyclic AMP-Dependent Protein KinasesCystic Fibrosis Transmembrane Conductance RegulatorDataDevelopmentDuct (organ) structureDuctal EpitheliumEarEdemaEndocrine systemEndolymphEndolymphatic HydropsEpithelialEpithelial CellsEpithelial PhysiologyEpitheliumEquilibriumExperimental DesignsExtracellular FluidGenesGlucocorticoidsHealthHearingHearing problemHomeostasisHormonalInvestigationIon ChannelIon TransportIon Transport AlterationIonsLabyrinthLeadLinkLiquid substanceMediatingMembraneMeniere&aposs DiseaseMessenger RNAMethodsMicrodissectionMolecularOrganPathologic ProcessesPathway interactionsPerilymphPhosphorylationPhysiologicalPositioning AttributePotassiumPreparationProcessPropertyProteinsRNARegulationResearch PersonnelRoleRouteScanningSemicircular canal structureSensorySeriesSignal PathwaySignal TransductionSliceSodiumStereociliumSurfaceSystemTechniquesTestingTissuesTranscriptTransport ProcessVestibular LabyrinthVestibular membraneWaterabsorptionadrenergicbasecalbindincell typeepithelial Na+ channelgenetic regulatory proteininterestknock-downnovelprogramsresponsesolutewater channel
项目摘要
DESCRIPTION (provided by applicant): Meniere's Disease is one of the pathological entities characterized by endolymphatic hydrops of the cochlear and vestibular labyrinths. Hydrops can result from an alteration of ion transport properties of the epithelial cells bordering the endolymphatic system. Little is known about the cellular basis of the pathologic processes involved because data are lacking from normal as well as pathological systems concerning mechanisms of secretion and absorption of ions. Endolymph is unique in that it is the only extracellular fluid in the body with a high potassium (K+) concentration and low sodium (Na+) and calcium (Ca2+) concentrations, a composition that is essential to sustain normal hearing and balance. Our understanding of transport processes in the inner ear has increased enormously over the previous periods of this award. However, two epithelial regions, Reissner's membrane (RM) in the cochlea and the semicircular canal ducts (SCCD) in the vestibular labyrinth, make important contributions to the homeostasis of endolymphatic fluid composition and volume, but our understanding of their functions lags behind that of other cell types in the ear. It is proposed to study the transport processes responsible for fluxes of the ions K+, Na+, CI-, HC03-, Ca2+ and water in the vestibular labyrinth and cochlea by RM and SCCD. These investigations will utilize our established microdissection, electrophysiologic, molecular biologic and immunohistochemical techniques as well as novel extensions of these (cochlear slice preparation to better preserve function of delicate tissues during isolation, conductance scanning to study paracellular transport pathways, fluctuation analysis of epithelial currents to determine ion channel properties and RNA inhibition to knock down the expression of specific genes). The experimental design will test a series of hypotheses about RM and SCCD transport that will lead to an understanding of fundamental, key roles of these epithelia in the health and disease of hearing and balance.
描述(由申请人提供):Meniere氏病是由耳蜗和前庭迷宫的内淋巴水滴特征的病理实体之一。水力可以是由与内淋巴系统接触的上皮细胞的离子转运性能改变产生的。关于涉及的病理过程的细胞基础知之甚少,因为从正常和病理系统中缺乏有关离子分泌和吸收机制的数据。内晶的独特之处在于它是体内唯一具有高钾(K+)浓度和低钠(Na+)和钙(Ca2+)浓度的细胞外液,这是维持正常听力和平衡至关重要的组合物。在该奖项的前期,我们对内耳运输过程的理解大大增加了。然而,在前庭迷宫中的耳蜗和半圆形管道(SCCD)中的两个上皮区域,Reissner的膜(RM),为内淋巴液液体组成和体积的稳态做出了重要贡献,但是我们对它们功能的理解落后于其他细胞类型的功能。提议研究负责由RM和SCCD在前庭迷宫中的离子K+,Na+,Ci-,HC03-,Ca2+和水的运输过程。这些研究将利用我们已建立的微分解,电生理学,分子生物学和免疫组织化学技术以及这些研究的新颖扩展(耳蜗切片的准备以更好地保留隔离组织的详细组织功能,在电导过程中,以研究偏细胞传输路径的特定性能,并确定降落层的表达性能,并确定降落性的倾向分析。基因)。实验设计将测试有关RM和SCCD运输的一系列假设,这些假设将导致对这些上皮的基本关键作用的理解在听力和平衡的健康和疾病中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL C MARCUS其他文献
DANIEL C MARCUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL C MARCUS', 18)}}的其他基金
相似国自然基金
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
- 批准号:82370796
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:32200798
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:82103851
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Development of microencapsulated PI301 targeting lung GABAergic signaling
开发针对肺 GABA 信号传导的微囊 PI301
- 批准号:
10478543 - 财政年份:2022
- 资助金额:
$ 36.03万 - 项目类别:
Mitigation of Exaggerated Smooth Muscle Force with Inhibitors of Integrin Alpha2Beta1
使用整合素 Alpha2Beta1 抑制剂缓解过度的平滑肌力
- 批准号:
10448088 - 财政年份:2022
- 资助金额:
$ 36.03万 - 项目类别:
Mitigation of Exaggerated Smooth Muscle Force with Inhibitors of Integrin Alpha2Beta1
使用整合素 Alpha2Beta1 抑制剂缓解过度的平滑肌力
- 批准号:
10629319 - 财政年份:2022
- 资助金额:
$ 36.03万 - 项目类别:
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
10160953 - 财政年份:2020
- 资助金额:
$ 36.03万 - 项目类别:
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
10472466 - 财政年份:2020
- 资助金额:
$ 36.03万 - 项目类别: